Posted by Michael Wonder on 17 May 2026
New medicines may be out of reach of PBS patients as Australia fails to adapt to ‘seismic market shifts’
18 May 2026 - Donald Trump’s medicines prices policy is causing global market disruption even as Australia’s broken approval processes leave patients increasingly vulnerable to missing innovative drugs.
Evidence is emerging that Australia is being reconsidered as a destination for the launch of a host of new drugs by pharmaceutical companies as US President Donald Trump’s medicines policies prompt “seismic shifts” in global pricing incentives that represent a critical threat to local patients.
